Anna Beronius

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: ENVIRONMENT INTERNATIONAL. 2025;197:109352
Using transcriptomics data and Adverse Outcome Pathway networks to explore endocrine disrupting properties of Cadmium and PCB-126
Wiklund L; Wincent E; Beronius A
Article: ENVIRONMENTAL SCIENCES EUROPE. 2025;37(1):19
Impact of the new hazard classes in the CLP regulation on EU chemicals legislation
Kattstrom D; Beronius A; af Gennas UB; Ruden C; Agerstrand M
Article: EVIDENCE-BASED TOXICOLOGY. 2024;2(1):2371285
Cross-mapping of terms used in chemical risk assessment with those used in systematic review: research protocol.
Svendsen C; Mathisen GH; Vist GE; Husøy T; Ames HM; Beronius A; Di Consiglio E; Druwe I; Hartung T; Hoffmann S; Hooijmans CR; Machera K; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Whaley P
Journal article: EVIDENCE-BASED TOXICOLOGY. 2024;2(1):2418045
A comprehensive item bank of internal validity issues of relevance to in vitro toxicology studies.
Vist GE; Ames HMR; Mathisen GH; Husøy T; Svendsen C; Beronius A; Consiglio ED; Druwe IL; Hartung T; Hoffmann S; Hooijmans CR; Machera K; Prieto P; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Whaley P
Article: ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY. 2024;43(11):2329-2337
AOP Report: An Upstream Network for Reduced Androgen Signaling Leading to Altered Gene Expression of Androgen Receptor-Responsive Genes in Target Tissues
Draskau MK; Rosenmai AK; Bouftas N; Johansson HKL; Panagiotou EM; Holmer ML; Elmelund E; Zilliacus J; Beronius A; Damdimopolou P; van Duursen M; Svingen T
Journal article: TOXICOLOGY LETTERS. 2024;399:s262
Development of an IATA for antiandrogen endocrine disruption
Beronius A; Vinggaard AM; Katsiadaki I; Bajard L; Mustafa E; Roncaglioni A; Sebire M; Spilioti E; Spyropoulou A; Sovadinova I; Knapen D; Jacobs M
Article: REPRODUCTIVE TOXICOLOGY. 2024;128:108662
Methodology for developing data-rich Key Event Relationships for Adverse Outcome Pathways exemplified by linking decreased androgen receptor activity with decreased anogenital distance
Holmer ML; Zilliacus J; Draskau MK; Hlisnikova H; Beronius A; Svingen T
Article: TOXICOLOGY. 2024;504:153794
Exploring a mechanism-based approach for the identification of endocrine disruptors using Adverse Outcome Pathways (AOPs) and New Approach Methodologies (NAMs) : A perfluorooctane sulfonic acid case study
Wiklund L; Pipal M; Weiss J; Beronius A
Article: ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS. 2024;26(2):380-399
Applying a modified systematic review and integrated assessment framework (SYRINA) - a case study on triphenyl phosphate
Bui TT; Aasa J; Abass K; Agerstrand M; Beronius A; Castro M; Escriva L; Galizia A; Gliga A; Karlsson O; Whaley P; Yost E; Ruden C
Article: HUMAN AND ECOLOGICAL RISK ASSESSMENT. 2024;30(1-2):122-137
Out of REACH: environmental hazards of cosmetic preservatives
Kattstrom D; Beronius A; af Gennas UB; Ruden C; Agerstrand M
Article: FRONTIERS IN TOXICOLOGY. 2024;6:1357717
Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity
Zilliacus J; Draskau MK; Johansson HKL; Svingen T; Beronius A
Article: FRONTIERS IN TOXICOLOGY. 2024;6:1452065
Fulfilling the criteria for CLP classification: the implications for substances under the EU chemicals legislation
Kattstrom D; Beronius A; Gennaes UBA; Ruden C; Agerstrand M
Article: OPEN RESEARCH EUROPE. 2024;4:68
Enhanced identification of endocrine disruptors through integration of science-based regulatory practices and innovative methodologies: The MERLON Project.
Svingen T; Andersson A-M; Angelova J; Axelstad M; Bakker J; Baumann L; Beronius A; Bouftas N; Chalmel F; Christiansen S; Cornil C; Damdimopoulou P; Deepika D; Dollé MET; Draskau MK; Fischer MB; Hagen CP; Hessel E; Holmer ML; Hughes S; Jensen G; Johansson HKL; Juul A; Kumar V; Kumar S; Lardenois A; Main KM; Mazaud-Guittot S; Moe SJ; Mola G; Parent A-S; Pineda R; Rolland A; Rosenmai AK; Song Y; Suglia A; Tena-Sempere M; Wehrli L; Zilliacus J; van Duursen M
Article: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. 2024;41(2):233-247
Beyond Chemicals: Opportunities and Challenges of Integrating Non-chemical Stressors in Adverse Outcome Pathways
Clerbaux L-A; Filipovska J; Nymark P; Chauhan V; Sewald K; Alb M; Sachana M; Beronius A; Amorim M-J; Wittwehr C
Journal article: EVIDENCE-BASED TOXICOLOGY. 2023;1(1):2293289
Protocol: Testing the Performance of INVITES-IN, A Tool for Assessing the Internal Validity of In Vitro Studies
Mathisen GH; Vist GE; Whaley P; White RA; Husøy T; Ames HM; Beronius A; Di Consiglio E; Druwe I; Hartung T; Hoffmann S; Hooijmans CR; Machera K; Prieto P; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Svendsen C
Article: EVIDENCE-BASED TOXICOLOGY. 2023;1(1):2232415-15
Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies.
Svendsen C; Whaley P; Vist GE; Husøy T; Beronius A; Consiglio ED; Druwe I; Hartung T; Hatzi VI; Hoffmann S; Hooijmans CR; Machera K; Robinson JF; Roggen E; Rooney AA; Roth N; Spilioti E; Spyropoulou A; Tcheremenskaia O; Testai E; Vinken M; Mathisen GH
Article: FRONTIERS IN TOXICOLOGY. 2023;5:1319985
SciRAPnano: a pragmatic and harmonized approach for quality evaluation of in vitro toxicity data to support risk assessment of nanomaterials
Shao G; Beronius A; Nymark P
Article: FRONTIERS IN TOXICOLOGY. 2023;5:1183824
Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities
Wiklund L; Caccia S; Pipal M; Nymark P; Beronius A
Article: ENVIRONMENTAL SCIENCES EUROPE. 2022;34(1):83
Characterisation and analysis of key studies used to restrict substances under REACH
Borchert F; Beronius A; Agerstrand M
Journal article: EFSA SUPPORTING PUBLICATIONS. 2022;19(7)
Training courses in risk assessment methodologies: uncertainty analysis, weight of evidence assessment and assessment of biological relevance
Beronius A; Craig P; Hanberg A; Hart A; Sahlin U; Zilliacus J
Article: TOXICOLOGY. 2022;476:153255
Systematic evaluation of the evidence for identification of endocrine disrupting properties of Bisphenol F
Wiklund L; Beronius A
Article: EFSA JOURNAL. 2022;20(Suppl 1):e200418
Assessment of endocrine disruptive properties of PFOS: EFSA/ECHA guidance case study utilising AOP networks and alternative methods
Pipal M; Wiklund L; Caccia S; Beronius A
Journal article: EFSA SUPPORTING PUBLICATIONS. 2022;19(5)
Evaluation of EFSA training courses on principles in chemical and biological risk assessment
Escher SE; Bruer G; Creutzenberg O; Schlemminger K; Schulz F; Ziemann C; Rorije E; van Klaveren J; Posthuma L; Bokkers B; Slob W; Hanberg A; Beronius A; Baumann L; Zilliacus J; Bitsch A
Article: CURRENT RESEARCH IN TOXICOLOGY. 2022;3:100065
Development of an adverse outcome pathway for intrahepatic cholestasis of pregnancy
Waspe J; Beronius A
Journal article: EMERGING CONTAMINANTS. 2022;8:229-242
Stricter regulation applies to antimicrobial substances when used as biocides compared to cosmetics under current EU legislation
Kattstrom D; Beronius A; Ruden C; Agerstrand M
Article: ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION. 2022;39(2):322-335
COVID-19 through Adverse Outcome Pathways: Building Networks to Better Understand the Disease-3rd CIAO AOP Design Workshop
Clerbaux L-A; Amigo N; Amorim MJ; Bal-Price A; Leite SB; Beronius A; Bezemer GFG; Bostroem A-C; Carusi A; Coecke S; Concha R; Daskalopoulos EP; Debernardi F; Edrosa E; Edwards SW; Filipovska J; Garcia-Reyero N; Gavins FNE; Halappanavar S; Hargreaves AJ; Hogberg HT; Huynh MT; Jacobson D; Josephs-Spaulding J; Kim YJ; Kong HJ; Krebs CE; Lam A; Landesmann B; Layton AR; Lee YO; Macmillan DS; Mantovani A; Margiotta-Casaluci L; Martens M; Masereeuw R; Mayasich SA; Mei LM; Mortensen H; Munoz A; Nymark P; Ohayon E; Ojasi JM; Paini A; Parissis N; Parvatam S; Pistollato F; Sachana M; Sorli JB; Sullivan KM; Sund J; Tanabe S; Tsaioun K; Vinken M; Viviani L; Waspe J; Willett C; Wittwehr C
Article: TOXICOLOGY. 2021;458:152843
An adverse outcome pathway on the disruption of retinoic acid metabolism leading to developmental craniofacial defects
Menegola E; Veltman CHJ; Battistoni M; Di Renzo F; Moretto A; Metruccio F; Beronius A; Zilliacus J; Kyriakopoulou K; Spyropoulou A; Machera K; van der Ven LTM; Luijten M
Article: ENVIRONMENTAL HEALTH. 2021;20(1):48
Assessment of the endocrine disrupting properties of bisphenol AF: a case study applying the European regulatory criteria and guidance
Escriva L; Zilliacus J; Hessel E; Beronius A
Article: ENVIRONMENT INTERNATIONAL. 2020;143:105926
Recommendations for the conduct of systematic reviews in toxicology and environmental health research (COSTER)
Whaley P; Aiassa E; Beausoleil C; Beronius A; Bilotta G; Boobis A; de Vries R; Hanberg A; Hoffmann S; Hunt N; Halsall C; Kwiatkowski CF; Lam J; Lipworth S; Martin O; Randall N; Rhomberg L; Rooney AA; Schunemann HJ; Wikoff D; Wolffe T; Halsall C
Article: FOOD AND CHEMICAL TOXICOLOGY. 2020;143:111520
Methodology for health risk assessment of combined exposures to multiple chemicals
Beronius A; Zilliacus J; Hanberg A; Luijten M; van der Voet H; van Klaveren J
Article: ENVIRONMENT INTERNATIONAL. 2020;142:105828
A validated search filter for the identification of endocrine disruptors based on the ECHA/EFSA guidance recommendations
Escriva L; Hessel E; Gustafsson S; van Spronsen R; Svanberg M; Beronius A
Article: FOOD AND CHEMICAL TOXICOLOGY. 2020;138:111185
The MCRA toolbox of models and data to support chemical mixture risk assessment
van der Voet H; Kruisselbrink JW; de Boer WJ; van Lenthe MS; van den Heuvel JJBH; Crepet A; Kennedy MC; Zilliacus J; Beronius A; Tebby C; Brochot C; Luckert C; Lampen A; Rorije E; Sprong C; van Klaveren JD
Article: HUMAN AND ECOLOGICAL RISK ASSESSMENT. 2020;26(1):212-241
Improving structure and transparency in reliability evaluations of data under REACH: suggestions for a systematic method
Ingre-Khans E; Agerstrand M; Ruden C; Beronius A
Article: EFSA JOURNAL. 2019;17(Suppl 2):e170914
Assessment of the endocrine disrupting properties of Bisphenol AF according to the EU criteria and ECHA/EFSA guidance
Escriva L; Hanberg A; Zilliacus J; Beronius A
Article: INTEGRATED ENVIRONMENTAL ASSESSMENT AND MANAGEMENT. 2019;15(3):458-469
Toxicity studies used in registration, evaluation, authorisation and restriction of chemicals (REACH): How accurately are they reported?
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Article: TOXICOLOGY RESEARCH. 2019;8(1):46-56
Reliability and relevance evaluations of REACH data
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Article: JOURNAL OF APPLIED TOXICOLOGY. 2018;38(12):1460-1470
Testing and refining the Science in Risk Assessment and Policy (SciRAP) web-based platform for evaluating the reliability and relevance of in vivo toxicity studies
Beronius A; Molander L; Zilliacus J; Ruden C; Hanberg A
Article: JOURNAL OF APPLIED TOXICOLOGY. 2018;38(5):783-785
A call for action: Improve reporting of research studies to increase the scientific basis for regulatory decision-making
Agerstrand M; Christiansen S; Hanberg A; Ruden C; Andersson L; Andersen S; Appelgren H; Bjorge C; Clausen IH; Eide DM; Hartmann NB; Husoy T; Halldorsson HP; van der Hagen M; Ingre-Khans E; Lillicrap AD; Beltoft VM; Mork A-K; Murtomaa-Hautala M; Nielsen E; Olafsdottir K; Palomaki J; Papponen H; Reiler EM; Stockmann-Juvala H; Suutari T; Tyle H; Beronius A
Article: TOXICOLOGY RESEARCH. 2017;6(5):571-577
Making the most of expert judgment in hazard and risk assessment of chemicals
Beronius A; Agerstrand M
Article: JOURNAL OF APPLIED TOXICOLOGY. 2017;37(3):319-330
Combining web-based tools for transparent evaluation of data for risk assessment: developmental effects of bisphenol A on the mammary gland as a case study
Molander L; Hanberg A; Ruden C; Agerstrand M; Beronius A
Article: ENVIRONMENTAL SCIENCE-PROCESSES & IMPACTS. 2016;18(12):1508-1518
Transparency of chemical risk assessment data under REACH
Ingre-Khans E; Agerstrand M; Beronius A; Ruden C
Article: ENVIRONMENTAL HEALTH. 2016;15(1):74
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicals
Vandenberg LN; Agerstrand M; Beronius A; Beausoleil C; Bergman A; Bero LA; Bornehag C-G; Boyer CS; Cooper GS; Cotgreave I; Gee D; Grandjean P; Guyton KZ; Hass U; Heindel JJ; Jobling S; Kidd KA; Kortenkamp A; Macleod MR; Martin OV; Norinder U; Scheringer M; Thayer KA; Toppari J; Whaley P; Woodruff TJ; Ruden C
Journal article: EFSA SUPPORTING PUBLICATIONS. 2016;13(5)
Review of non‐monotonic dose‐responses of substances for human risk assessment
Beausoleil C; Beronius A; Bodin L; Bokkers BGH; Boon PE; Burger M; Cao Y; De Wit L; Fischer A; Hanberg A; Leander K; Litens‐Karlsson S; Rousselle C; Slob W; Varret C; Wolterink G; Zilliacus J
Article: HUMAN AND ECOLOGICAL RISK ASSESSMENT. 2015;21(3):753-762
Science in Risk Assessment and Policy (SciRAP): An Online Resource for Evaluating and Reporting In Vivo (Eco)Toxicity Studies
Molander L; Agerstrand M; Beronius A; Hanberg A; Ruden C
Article: CURRENT OPINION IN PHARMACOLOGY. 2014;19:99-104
Bridging the gap between academic research and regulatory health risk assessment of Endocrine Disrupting Chemicals
Beronius A; Hanberg A; Zilliacus J; Ruden C
Journal article: REPRODUCTIVE TOXICOLOGY. 2014;48:18
How can academic research studies fill important information gaps in regulatory risk assessment? – The example of developmental neurotoxicity of bisphenol A
Beronius A
Article: JOURNAL OF APPLIED TOXICOLOGY. 2014;34(6):607-617
Facilitating the use of non-standard in vivo studies in health risk assessment of chemicals: a proposal to improve evaluation criteria and reporting
Beronius A; Molander L; Ruden C; Hanberg A
Article: TOXICOLOGY. 2013;311(1-2):13-26
The influence of study design and sex-differences on results from developmental neurotoxicity studies of bisphenol A, implications for toxicity testing
Beronius A; Johansson N; Ruden C; Hanberg A
Article: REPRODUCTIVE TOXICOLOGY. 2010;29(2):132-146
Risk to all or none? A comparative analysis of controversies in the health risk assessment of Bisphenol A
Beronius A; Ruden C; Hakansson H; Hanberg A
Article: REGULATORY TOXICOLOGY AND PHARMACOLOGY. 2009;55(2):111-122
Health risk assessment procedures for endocrine disrupting compounds within different regulatory frameworks in the European Union
Beronius A; Ruden C; Hanberg A; Hakansson H
Visa fler

Anställningar

Senior Forskare, Institutet för miljömedicin, Karolinska Institutet, 2025-
Senior Forskningsspecialist, Institutet för miljömedicin, Karolinska Institutet, 2022-2025

Examina och utbildning

Docent, Toxikologi, Karolinska Institutet, 2022
Medicine Doktorsexamen, Institutet för miljömedicin, Karolinska Institutet, 2013

Artiklar

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI